Home
Scholarly Works
Counting what really counts: the irinotecan in...
Journal article

Counting what really counts: the irinotecan in recurrent glioblastoma trial

Authors

Streiner DL; Streiner DL

Journal

Community Oncology, Vol. 8, No. 9, pp. 425–426

Publisher

Elsevier

Publication Date

January 1, 2011

DOI

10.1016/s1548-5315(12)70093-1

ISSN

1548-5315

Contact the Experts team